Commonwealth Equity Services, LLC Oncocyte Corp Transaction History

Commonwealth Equity Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 05, 2020	SELL	$1.51 - $2.27 $53,145 - $79,894	-35,196 Closed	0 $0
Q3 2019 Oct 30, 2019	SELL	$1.59 - $2.51 $15 - $25	-10 Reduced 0.03%	35,196 $73,000
Q2 2019 Jul 19, 2019	BUY	$2.49 - $5.45 $12,948 - $28,340	5,200 Added 17.33%	35,206 $87,000
Q1 2019 May 13, 2019	BUY	$1.47 - $5.91 $1,199 - $4,822	816 Added 2.8%	30,006 $118,000
Q4 2018 Feb 11, 2019	BUY	$1.38 - $2.59 $6,940 - $13,025	5,029 Added 20.81%	29,190 $40,000
Q3 2018 Nov 06, 2018	BUY	$2.2 - $3.45 $53,154 - $83,355	24,161 New	24,161 $60,000

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $304M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.